1. miR-210 hypoxamiR in Angiogenesis and Diabetes.
- Author
-
Zaccagnini, Germana, Greco, Simona, Voellenkle, Christine, Gaetano, Carlo, and Martelli, Fabio
- Subjects
- *
NEOVASCULARIZATION , *CARDIOVASCULAR diseases , *DIABETES , *GENE ontology , *CELL proliferation , *CELL migration inhibition , *MICRORNA - Abstract
Significance: microRNA-210 (miR-210) is the master hypoxia-inducible miRNA (hypoxamiR) since it has been found to be significantly upregulated under hypoxia in a wide range of cell types. Recent advances: Gene ontology analysis of its targets indicates that miR-210 modulates several aspects of cellular response to hypoxia. Due to its high pleiotropy, miR-210 not only plays a protective role by fine-tuning mitochondrial metabolism and inhibiting red-ox imbalance and apoptosis, but it can also promote cell proliferation, differentiation, and migration, substantially contributing to angiogenesis. Critical issues: As most miRNAs, modulating different gene pathways, also miR-210 can potentially lead to different and even opposite effects, depending on the physio-pathological contexts in which it acts. Future direction: The use of miRNAs as therapeutics is a fast growing field. This review aimed at highlighting the role of miR-210 in angiogenesis in the context of ischemic cardiovascular diseases and diabetes in order to clarify the molecular mechanisms underpinning miR-210 action. Particular attention will be dedicated to experimentally validated miR-210 direct targets involved in cellular processes related to angiogenesis and diabetes mellitus, such as mitochondrial metabolism, redox balance, apoptosis, migration, and adhesion. Antioxid. Redox Signal. 36, 685โ706. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF